302 related articles for article (PubMed ID: 36055875)
1. No significant increase in Guillain-Barré syndrome after COVID-19 vaccination in adults: A vaccine adverse event reporting system study.
Jaffry M; Mostafa F; Mandava K; Rosario S; Jagarlamudi Y; Jaffry K; Kornitzer J; Jedidi K; Khan H; Souayah N
Vaccine; 2022 Sep; 40(40):5791-5797. PubMed ID: 36055875
[TBL] [Abstract][Full Text] [Related]
2. Association of Receipt of the Ad26.COV2.S COVID-19 Vaccine With Presumptive Guillain-Barré Syndrome, February-July 2021.
Woo EJ; Mba-Jonas A; Dimova RB; Alimchandani M; Zinderman CE; Nair N
JAMA; 2021 Oct; 326(16):1606-1613. PubMed ID: 34617967
[TBL] [Abstract][Full Text] [Related]
3. Reports of Guillain-Barré Syndrome After COVID-19 Vaccination in the United States.
Abara WE; Gee J; Marquez P; Woo J; Myers TR; DeSantis A; Baumblatt JAG; Woo EJ; Thompson D; Nair N; Su JR; Shimabukuro TT; Shay DK
JAMA Netw Open; 2023 Feb; 6(2):e2253845. PubMed ID: 36723942
[TBL] [Abstract][Full Text] [Related]
4. COVID-19 vaccination and Guillain-Barré syndrome: analyses using the National Immunoglobulin Database.
Keh RYS; Scanlon S; Datta-Nemdharry P; Donegan K; Cavanagh S; Foster M; Skelland D; Palmer J; Machado PM; Keddie S; Carr AS; Lunn MP;
Brain; 2023 Feb; 146(2):739-748. PubMed ID: 35180300
[TBL] [Abstract][Full Text] [Related]
5. Guillain-Barré syndrome after COVID-19 vaccination: A systematic review and analysis of case reports.
Abuawwad MT; Taha MJJ; Taha AJ; Kozaa YA; Falah O; Abuawwad IT; Hammad EM; Mahmoud AA; Aladawi M; Serhan HA
Clin Neurol Neurosurg; 2024 Mar; 238():108183. PubMed ID: 38401232
[TBL] [Abstract][Full Text] [Related]
6. Risk of Guillain-Barré Syndrome Following COVID-19 Vaccines: A Nationwide Self-Controlled Case Series Study.
Le Vu S; Bertrand M; Botton J; Jabagi MJ; Drouin J; Semenzato L; Weill A; Dray-Spira R; Zureik M
Neurology; 2023 Nov; 101(21):e2094-e2102. PubMed ID: 37788935
[TBL] [Abstract][Full Text] [Related]
7. Guillain-Barré syndrome temporally associated with COVID-19 vaccines in Victoria, Australia.
Osowicki J; Morgan HJ; Harris A; Clothier HJ; Buttery JP; Kiers L; Crawford NW;
Vaccine; 2022 Dec; 40(52):7579-7585. PubMed ID: 36357291
[TBL] [Abstract][Full Text] [Related]
8. Guillain-Barré syndrome and COVID-19 vaccination: a systematic review and meta-analysis.
Censi S; Bisaccia G; Gallina S; Tomassini V; Uncini A
J Neurol; 2024 Mar; 271(3):1063-1071. PubMed ID: 38233678
[TBL] [Abstract][Full Text] [Related]
9. Real-world data on the incidence and risk of Guillain-Barré syndrome following SARS-CoV-2 vaccination: a prospective surveillance study.
Ha J; Park S; Kang H; Kyung T; Kim N; Kim DK; Kim H; Bae K; Song MC; Lee KJ; Lee E; Hwang BS; Youn J; Seok JM; Park K
Sci Rep; 2023 Mar; 13(1):3773. PubMed ID: 36882454
[TBL] [Abstract][Full Text] [Related]
10. Rare cases of Guillain-Barré syndrome after COVID-19 vaccination, Germany, December 2020 to August 2021.
Lehmann HC; Oberle D; Keller-Stanislawski B; Rieck T; Streit R
Euro Surveill; 2023 Jun; 28(24):. PubMed ID: 37318764
[TBL] [Abstract][Full Text] [Related]
11. Associations of Guillain-Barré syndrome with coronavirus disease 2019 vaccination: Disproportionality analysis using the World Health Organization pharmacovigilance database.
Kim JE; Park J; Min YG; Hong YH; Song TJ
J Peripher Nerv Syst; 2022 Sep; 27(3):206-214. PubMed ID: 35751472
[TBL] [Abstract][Full Text] [Related]
12. Association Between Guillain-Barré Syndrome and COVID-19 Infection and Vaccination: A Population-Based Nested Case-Control Study.
Bishara H; Arbel A; Barnett-Griness O; Bloch S; Cohen S; Najjar-Debbiny R; Gronich N; Auriel E; Saliba W
Neurology; 2023 Nov; 101(20):e2035-e2042. PubMed ID: 37852786
[TBL] [Abstract][Full Text] [Related]
13. Post-marketing active surveillance of Guillain Barré Syndrome following COVID-19 vaccination in persons aged ≥12 years in Italy: A multi-database self-controlled case series study.
Morciano C; Spila Alegiani S; Menniti Ippolito F; Belleudi V; Trifirò G; Zanoni G; Puccini A; Sapigni E; Mores N; Leoni O; Monaco G; Clagnan E; Zappetti C; Bovo E; Cutillo M; Da Cas R; Massari M
PLoS One; 2024; 19(1):e0290879. PubMed ID: 38241309
[TBL] [Abstract][Full Text] [Related]
14. Incidence of Guillain-Barré Syndrome After COVID-19 Vaccination in the Vaccine Safety Datalink.
Hanson KE; Goddard K; Lewis N; Fireman B; Myers TR; Bakshi N; Weintraub E; Donahue JG; Nelson JC; Xu S; Glanz JM; Williams JTB; Alpern JD; Klein NP
JAMA Netw Open; 2022 Apr; 5(4):e228879. PubMed ID: 35471572
[TBL] [Abstract][Full Text] [Related]
15. Guillain-Barré syndrome after COVID-19 vaccines: A Tunisian case series.
Berrim K; Lakhoua G; Zaiem A; Charfi O; Aouinti I; Kastalli S; Daghfous R; El Aidli S
Br J Clin Pharmacol; 2023 Feb; 89(2):574-578. PubMed ID: 36398559
[TBL] [Abstract][Full Text] [Related]
16. Guillain-Barré syndrome following influenza vaccination.
Haber P; DeStefano F; Angulo FJ; Iskander J; Shadomy SV; Weintraub E; Chen RT
JAMA; 2004 Nov; 292(20):2478-81. PubMed ID: 15562126
[TBL] [Abstract][Full Text] [Related]
17. Optic Neuritis After COVID-19 Vaccination: An Analysis of the Vaccine Adverse Event Reporting System.
Jaffry M; Aftab OM; Mostafa FB; Faiz I; Jaffry K; Mandava K; Rosario S; Jedidi K; Khan H; Souayah N
J Neuroophthalmol; 2023 Dec; 43(4):499-503. PubMed ID: 37314860
[TBL] [Abstract][Full Text] [Related]
18. Guillain-Barré syndrome after influenza vaccination in the United States, a report from the CDC/FDA vaccine adverse event reporting system (1990-2009).
Souayah N; Yacoub HA; Khan HM; Farhad K; Mehyar LS; Maybodi L; Menkes DL; Qureshi AI
J Clin Neuromuscul Dis; 2012 Dec; 14(2):66-71. PubMed ID: 23172385
[TBL] [Abstract][Full Text] [Related]
19. Guillain-Barré syndrome after H1N1 vaccination in the United States: a report using the CDC/FDA Vaccine Adverse Event Reporting System (2009).
Souayah N; Yacoub HA; Khan HM; Michas-Martin PA; Menkes DL; Maybodi L; Qureshi AI
Neuroepidemiology; 2012; 38(4):227-32. PubMed ID: 22555646
[TBL] [Abstract][Full Text] [Related]
20. Guillain-Barré syndrome after vaccination in United States: data from the Centers for Disease Control and Prevention/Food and Drug Administration Vaccine Adverse Event Reporting System (1990-2005).
Souayah N; Nasar A; Suri MF; Qureshi AI
J Clin Neuromuscul Dis; 2009 Sep; 11(1):1-6. PubMed ID: 19730016
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]